Broker Recommendations and Target Prices for the H-share of the Industrial and Commercial Bank of China (ICBC)

Introduction

In a previous article, I laid out the reasons why I added the H-share of the Industrial and Commercial Bank of China (ICBC) to my dividend income portfolio. In the same article I also described the discounted cash flow analysis which I used to estimate the intrinsic value of ICBC H-share, which worked out to be 5.83HK$ per share.

Not long after the article was posted on my blog, I came across a piece of news article on AAStocks.com which provided a summary of the latest Brokers' Recommendations and Target Prices for ICBC H-share (1398.HK).

The table is reproduced below.

Summary Table of Broker Recommendations and Target Prices for ICBC H-share (1398.HK)

BrokerTarget Price (HK$)Recommendation
CICC8.19Outperform
Morgan Stanley7.2Overweight
HSBC Global Research7.1Buy
Citigroup6.99Buy
UOB Kay Hian6.7Buy
BofA Securities6.6Buy
BOCOMI6.6Buy
UBS6.5Buy
BNP Paribas6.5Buy
Nomura6.38Buy
Credit Suisse6.3Outperform
CCBI6.3Outperform
Goldman Sachs6.23Buy
CITIC Securities6Overweight
CMSI5.3Buy
JP Morgan5.3Neutral
Jefferies4.99Buy
Macquarie4.4Neutral
Data Source: AAStocks.com  

Average of the Broker target prices for ICBC H-share

The average of the target prices from all the different brokers = 6.31HK$ per share. This compares favourably with the estimate of the intrinsic value of ICBC H-share of 5.83HK$. It also indicates that the dividend discount model which was used in my analysis probably errs on the side of caution.

H-share of ICBC has sufficent margin of safety to allow an investor to sleep well at night

Assuming that the average target price of 6.31HK$ per share is a reasonable estimate of the intrinsic value of ICBC H-share based on the collective wisdom of the different Research Houses, the margin of safety represented by the purchase price of 4.29HK$ is 32%. This is certainly a comfortable margin which allows an investor in ICBC H-share to sleep well at night.

Disclaimer:

This article is a record of the thinking behind a personal investment decision. It does not represent any recommendation to purchase any stock mentioned in the article. As always, readers are strongly advised to do their own due diligence before making any investment decisions.